- XLYMarket Realist•1 hour ago
Last week, mainstream auto companies (XLY) traded mostly on a mixed note. In the week ending September 23, 2016, GM ended the week with gains of 3.7%.
- XLVMarket Realist•1 hour ago
On September 21, 2016, the FDA approved Jannsen Pharmaceuticals’ Invokamet XR for the treatment of adults suffering from Type 2 diabetes.